Literature DB >> 73853

Comparison of vitamin D and 25-hydroxy-vitamin-D in the therapy of primary biliary cirrhosis.

J B Wagonfeld, B A Nemchausky, M Bolt, J V Horst, J L Boyer, I H Rosenberg.   

Abstract

Skeletal demineralisation and low serum concentrations of 25-hydroxy-vitamin-D were observed in patients with primary biliary cirrhosis. Neither oral nor parenteral vitamin-D increased 25-hydroxy-vitamin-D in serum or prevented further skeletal demineralisation. In contrast, oral 25-hydroxy-vitamin-D increased serum-25-hydroxy-vitamin D concentrations in all patients, and bone mineral content either improved or stabilised in all but one, 25-hydroxy-vitamin-D may be the preferred form of vitamin-D therapy in primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 73853     DOI: 10.1016/s0140-6736(76)92407-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

1.  Perspective in liver disease: An Irish experience.

Authors:  M J Whelton
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

2.  Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels.

Authors:  D D Bikle; B P Halloran; E Gee; E Ryzen; J G Haddad
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

Review 3.  Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease.

Authors:  J E Compston
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

4.  Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease.

Authors:  R G Long; E Meinhard; R K Skinner; Z Varghese; M R Wills; S Sherlock
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

Review 5.  Vitamin d deficiency in patients with chronic liver disease and cirrhosis.

Authors:  Lei Yuan Lim; Naga Chalasani
Journal:  Curr Gastroenterol Rep       Date:  2012-02

6.  Osteomalacia in chronic liver disease.

Authors:  J B Dibble; M S Losowsky
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-17

7.  Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25-hydroxyvitamin D3.

Authors:  J E Compston; L W Horton; R P Thompson
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

Review 8.  25 Hydroxyvitamin D and vitamin E absorption in healthy children and children with chronic intrahepatic cholestasis.

Authors:  S Issa; H W Rotthauwe; W Burmeister
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

9.  Parenteral 1,25-dihydroxycholecalciferol in hepatic osteomalacia.

Authors:  R G Long; Z Varghese; E A Meinhard; R K Skinner; M R Wills; S Sherlock
Journal:  Br Med J       Date:  1978-01-14

10.  Vitamin D deficiency, osteomalacia, and primary biliary cirrhosis. Response to orally administered vitamin D3.

Authors:  M Davies; E B Mawer; H J Klass; G A Lumb; J L Berry; T W Warnes
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.